Chemo-immunotherapy by dual-enzyme responsive peptide self-assembling abolish melanoma

Yuhan Wang,Limin Xie,Xinxin Li,Ling Wang,Zhimou Yang

DOI: https://doi.org/10.1016/j.bioactmat.2023.09.006

IF: 18.9

2023-09-18

Bioactive Materials

Abstract:Highlights • Comp. 1 with dual-enzyme responsiveness can be controlled by microenvironment to realize accurate delivery of loaded therapeutic agents. • Functional components of Comp. 1 endow it with the ability to recognize tumor characteristics. • Combined chemotherapy and tumor-specific immunotherapy are used for precise therapy of highly invasive malignant tumors. Herein, we designed Comp. 1 to simultaneously respond to two enzymes: alkaline phosphatase and matrix metalloproteinase 2, which is commonly found in highly malignant cancer cell lines containing B16–F10 murine melanoma cells and CT26 murine colon carcinoma cells. We used the regional differences in the expression levels of dual-markers to accurately release immune molecule IND into tumor microenvironment for the activation of anti-tumor related immune effects, while in-situ self-assembly occurs. The dual-enzyme response process can further regulate the peptide precursors' self-assembly in the form of short rod-shaped nanofibers, enabling the delivery of the loaded chemotherapeutic drug HCPT into the cancer cells and further allowing the peptide assemblies to escape from lysosomes and return to cytoplasm in the form of tiny nanoparticles to induce apoptosis of cancer cells. This process does not occur in the single-positive breast cancer cell line MCF-7 or the normal hepatocytes cell line LO2, indicating the selectivity of the cancer cells exhibited using our strategy. In vivo studies revealed that Comp. 1 can effectively cooperate with chemotherapy to enhance the immunotherapy effect and induce immune responses associated with elevated pro-inflammatory cytokines in vivo to inhibit malignant tumors growth. Our dual-enzyme responsive chemo-immunotherapy strategy feasible in anti-tumor treatment, provides a new avenue for regulating peptide self-assembly to adapt to diverse tumor properties and may eventually be used for the development of novel multifunctional anti-tumor nanomedicines. Graphical abstract The dual-enzyme response process regulates the in situ self-assembly of peptide precursors to form nanofibers, simultaneously realizes the release of immune molecule IND in the tumor microenvironment, and delivers the loaded chemotherapeutic drug HCPT into cancer cells. After internalization, lysosomes escape is achieved and return to the cytoplasm in the form of tiny nanoparticles to induce apoptosis of cancer cells. This novel strategy has been demonstrated to be a powerful strategy for inhibiting the growth of malignant tumors. Download : Download high-res image (345KB) Download : Download full-size image

engineering, biomedical,materials science, biomaterials